SYDNEY, AUSTRALIA–(Marketwire – December 2, 2010) –  Sunshine Heart Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate to severe heart failure, today announced the successful completion of its non-renounceable rights issue to existing shareholders, raising a total of A$9.5 million.

88 per cent of entitlements were taken up under the rights issue including the shortfall facility, leaving 44,761,462 shares unsubscribed.

The rights issue follows the Company’s recent successful placement to US institutional investors raising A$3.7 million (announced 16 September 2010), bringing the total proceeds to A$13.2 million before deducting fees and expenses.

Majority Australian shareholders, GBS Venture Partners and CM Capital, both continued their strong support for the Company, taking up their full entitlements and also some of the shortfall, for an aggregate amount of $6.6 million

Sunshine Heart Chief Executive Officer Dave Rosa said, “We are delighted to have such strong support from existing shareholders and welcome new US institutional investors during this exciting and pivotal period for Sunshine Heart.”

The capital will be used to fund the key activities of the Company. The most important of these is to advance the regulatory trials in the US by completing the current 20-patient feasibility trial and six-month patient follow up, then preparing the application for the larger FDA pivotal trial which is the precursor for marketing approval in the USA. The Company expects to have approval for this trial and to start implants during 2011.

The money will also be used to apply for CE Mark approval in 2011 which will allow the C-Pulse heart assist device to be marketed in Europe and parts of Asia.

The Company will continue its development of a new, single unit C-Pulse driver as well as introducing product changes to facilitate minimally invasive implant procedures.

The successful US placement was managed by specialist healthcare investment firm Summer Street Research Partners Inc. The non-renounceable rights issue was managed by RBS Morgans in Australia.

About Sunshine Heart Inc.
Sunshine Heart Inc. (ASX: SHC), a global medical device company focused on innovative technologies for the treatment of moderate heart failure, is commercializing the C-Pulse® Heart Assist System, a minimally invasive, implantable, non-blood contacting, heart assist therapy for the treatment of moderate heart failure. The C-Pulse System is designed to relieve the symptoms of heart failure through the use of counterpulsation technology which enables an increase in cardiac output, an increase in coronary blood flow and a reduction in the heart’s pumping load. The Company has received approval from the US Food and Drug Administration (FDA) to conduct a 20-patient U.S. feasibility clinical trial with the C-Pulse System and the study has achieved eighty percent enrolment as of November 2010. Sunshine Heart, Inc. is a Delaware-based Corporation headquartered in Minneapolis with a subsidiary presence in Australia.

About the C-Pulse® Heart Assist System
The C-Pulse Heart Assist System uses proprietary balloon counterpulsation technology to increase the amount of blood pumped by the heart and to reduce the workload on the heart. The C-Pulse System is implanted in the patient’s chest through a sternotomy or through a small incision when performed as a minimally invasively procedure. During the procedure, there is no need to place the patient on a heart-lung machine as the patient’s heart remains beating continuously. 

Once implanted, the C-Pulse cuff is positioned on the outside of the patient’s ascending aorta above the aortic valve. An ECG sense lead is then attached to the heart to determine timing for cuff inflation and deflation in synchronization with the heartbeat. The C-Pulse cuff and lead are connected to a single line that is run through the abdomen to connect to a power driver outside the body. Because the C-Pulse System remains outside the blood system, there is potentially less risk of blood clots and stroke in comparison to other mechanical devices, such as left ventricle assist devices (LVADs).

This press release contains forward-looking statements that are based on current management expectations. These statements may differ materially from actual future events or results due to certain risks and uncertainties from time to time in the Company’s filings with the Australian Securities Exchange. The shares of Sunshine Heart have not been registered under the Securities Act of 1933 (US Securities Act) and may not be offered, sold or delivered in the United States, or to, or for the account or benefit of, any US Person, as such term is defined in Regulation S of the US Securities Act. In addition, hedging transactions with regard to the shares may not be conducted unless in accordance with the US Securities Act.

Click here to see all recent news from this company

CHICAGO, IL–(Marketwire – December 2, 2010) – Based on mutual interest in the use of effective and productive electronic data interchange standards in the health care industry, the Healthcare Information and Management Systems (HIMSS) and the Accredited Standards Committee X12 (ASC X12) signed a Memorandum of Understanding formalizing their decision to collaborate on activities and offerings that improve or enhance the implementation of EDI standards in the health care industry.

“ASC X12 and HIMSS have established a cooperative relationship, taking advantage of each organization’s strengths. We look forward to many productive joint initiatives,” said Cathy Sheppard, Chair, ASC X12.

The two organizations intend to collaborate in the development of educational materials, conference presentations, webinars, white papers, articles and reports.

Such cooperative efforts are not new between the organizations, HIMSS and ASC X12 have developed and presented a comprehensive overview of ASC X12 005010 migrations in the Webinar HIPAA 005010 Road to Success — A Prescription for a Healthy and Successful ASC X12 005010 Implementation. HIMSS also published the article ASC X12’s Emerging 5010 Activities, by Cathy Sheppard, in their August 2010 Business Edge online newsletter.

January 1, 2012 is the deadline for health care organizations to be compliant with the ASC X12 005010 transactions mandated by the Health Insurance Reform: Modifications to the Health Insurance Portability and Accountability Act (HIPAA) Electronic Transaction Standards Final Rule (also known as the 005010 Final Rule). ASC X12 and HIMSS are committed to aiding stakeholders in compliance preparation. 

ASC X12N (Insurance) Vice Chair, Bob Poiesz, will serve on an ASC X12 005010 migration panel at the HIMSS11 Annual Conference and Exhibition. The Ninth National Medical Banking Institute, to be held in conjunction with HIMSS11, features national experts and cross-industry leaders from health care, banking, financial systems, government and academia for an interactive dialogue of critical issues and next steps on building the future of medical banking. At the HIMSS Medical Banking Boot Camp ASC X12 will describe 005010 health data transactions mandated by HIPAA and identify the steps a provider will need to take as part of the ASC X12 005010 transition.

“HIMSS and our medical banking and financial systems community welcome the opportunity to work with the Accredited Standards Committee X12 to build awareness and better educate our diverse audiences, on the value of efficient data exchange in health care,” said John Casillas, HIMSS Senior Vice President, Business-Centered Systems. “With this MoU, our organizations can work together to build relationships and develop educational programming that improves the delivery of health care.”

About HIMSS
HIMSS is a cause-based, not-for-profit organization exclusively focused on providing global leadership for the optimal use of information technology (IT) and management systems for the betterment of healthcare. Founded 50 years ago, HIMSS and its related organizations have offices in Chicago, Washington, DC, Brussels, Singapore, Leipzig, and other locations across the United States. HIMSS represents more than 30,000 individual members, of which two thirds work in healthcare provider, governmental and not-for-profit organizations. HIMSS also includes over 470 corporate members and more than 85 not-for-profit organizations that share our mission of transforming healthcare through the effective use of information technology and management systems. HIMSS frames and leads healthcare practices and public policy through its content expertise, professional development, and research initiatives designed to promote information and management systems’ contributions to improving the quality, safety, access, and cost-effectiveness of patient care. To learn more about HIMSS and to find out how to join us and our members in advancing our cause, please visit our website at www.himss.org.

About X12
ASC X12, chartered by the American National Standards Institute more than 30 years ago, develops and maintains EDI and CICA standards along with XML schemas which drive business processes globally. The diverse membership of ASC X12 includes technologists and business process experts, encompassing health care, insurance, transportation, finance, government, supply chain and other industries. For more information, visit the ASC X12 website at www.x12.org

MOUNT PLEASANT, MI–(Marketwire – December 2, 2010) – Following more than two years of exploration, comprehensive study and due diligence, Central Michigan University will establish a relationship with Synergy Medical Education Alliance, Covenant Healthcare and St. Mary’s of Michigan in Saginaw, Mich., through its College of Medicine.

The CMU Board of Trustees, at its Dec. 2 meeting, voted unanimously to establish a new 501(c)(3) Michigan nonprofit corporation, Central Health Advancement Solutions, to serve as the University’s participant in clinical practice entities and medical education relationships.

The boards of St. Mary’s of Michigan and Synergy Medical Education Alliance must approve the agreement. It is anticipated that the required board approvals will be secured by mid-December. Covenant Healthcare’s board has already approved the agreement.

Under the terms of the agreement, if approved, CMU will join in the Synergy Medical Education Alliance partnership and the organization will be renamed CMU Medical Education Partners.

CMU has been engaged in the Saginaw community since the 1970s providing extended and distance learning programs and remains committed to enhancing its engagement through a facility in the Saginaw area to support medical education and clinical practice needs.

In other College of Medicine action, CMU trustees established a Doctor of Medicine degree. The four-year curriculum, with an emphasis on placing doctors in rural settings, will focus on evidence-based practice, patient-centered care, team-based learning and practice, and self-directed lifelong learning.

To view today’s PowerPoint presentation to the board visit http://www.cmich.edu/documents/college_of_medicine/collegeofmedicinepresentation_120210.pdf.

To learn more about CMU’s College of Medicine visit http://www.cmich.edu/med.

For additional news from Central Michigan University, visit the CMU Media Channel at http://www.cmich.edu/mediachannel.

Click here to see all recent news from this company

REDWOOD SHORES, CA–(Marketwire – December 2, 2010) – Oracle (NASDAQ: ORCL)

News Facts

• To provide the best patient care, the University of Chicago Medical Center is running its critical patient care applications on Oracle’s Sun SPARC Enterprise M-Series Servers with Oracle Solaris.
• The University of Chicago Medical Center (UCMC) is an academic medical center comprised of numerous hospitals, including Bernard A. Mitchell Hospital, Comer Children’s Hospital, Chicago Lying-in Hospital, Duchossois Center for Advanced Medicine and the University of Chicago Pritzker School of Medicine, as well as physician offices in several Chicago locations.
• UCMC chose Oracle’s Sun SPARC Enterprise M-Series servers running Oracle Solaris for their high level of performance, scalability and availability to run its mission-critical applications, including the Epic Electronic Medical Record (EMR) and Computerized Physician Order Entry (CPOE) systems.
• More than 6,000 clinical staff rely on the Epic EMR system to deliver 24×7 secure access to all relevant information necessary to provide high-quality patient care, including lab results, orders, documentation on care plans, operating room management and scheduling, reporting and patient portals.
• With Oracle’s Sun SPARC Enterprise M-Series servers running Oracle Solaris, UCMC has increased performance by 40 percent, decreased maintenance costs and reduced power and cooling by 63 percent in the datacenter.
• With the new platform, nurses and physicians experience rapid response times, enabling them to provide patient care in a more timely and efficient manner, which is key in hospital and critical-care environments.
• Part of UCMC’s strategic five-year plan, the SPARC servers provide the capacity to support new initiatives and continued growth, including the deployment of new EMR modules and technology to support a new hospital coming online in 2013.
• UCMC invested in Oracle’s Sun SPARC Enterprise M-Series servers with Oracle Solaris in March 2010.

Supporting Quote

• “Oracle’s Sun SPARC Enterprise servers provide us with a secure and reliable platform to run our mission-critical patient care applications and the ability to easily scale to accommodate future growth,” said Michael Sorensen, Executive Director and CTO, IT Services, the University of Chicago Medical Center. “The new platform has delivered dramatic results, including significantly faster response times, which is instrumental in our ability to provide patients with the best care.”

Supporting Resources

• University of Chicago Medical Center
• Oracle’s Sun SPARC Enterprise M-Series Servers
• Oracle Solaris
• Oracle in Healthcare
• Follow Oracle Health Sciences on Twitter
• Join the Oracle Health Sciences Community on Facebook

About Oracle
Oracle (NASDAQ: ORCL) is the world’s most complete, open and integrated business software and hardware systems company. For more information about Oracle, please visit http://www.oracle.com.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

TOLEDO, OH–(Marketwire – December 2, 2010) – Cardiothoracic Surgeons for Northwest Ohio and The Toledo Hospital are now in the nation’s top 12% of hospitals for heart surgery. This is according to a three-star comprehensive rating system, developed by The Society of Thoracic Surgeons (STS), which compares the quality of heart surgery in hospitals across the country. A three-star rating is the highest designation that a hospital can attain for quality and clinical excellence. Cardiothoracic Surgeons for Northwest Ohio was compared to more than 1,000 surgical groups.

Hospitals are scored on performance in the following four categories — patient survival, absence of surgical complications, recommended medications, and optimal surgical technique. The ratings reflect results from isolated heart-bypass operations called coronary artery bypass grafting to newer versions, which include minimally invasive bypass and other complex cardiac procedures.

“I am grateful to my partners and colleagues at The Toledo Hospital who have worked diligently for years to reach this incredible milestone,” said Michael Moront, MD, senior partner, Cardiothoracic Surgeons for Northwest Ohio. “When patients enter our doors, they can feel confident that they will be receiving the very best care from one of the nation’s leading medical groups.”

Consumers can easily see how surgical groups compare with national benchmarks for survival, complications, and other measures by visiting www.consumerhealthreports.org.

About STS
The Society of Thoracic Surgeons is a not-for-profit organization representing more than 6,000 surgeons, researchers and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus as well as other surgical procedures within the chest. Founded in 1964, the mission of STS is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy. Its National Adult Cardiac Surgery Database includes more than 4 million surgical records and covers roughly 90% of the more than 1,000 surgical groups in the U.S. that perform cardiac surgery, making it the largest such registry in the world.

About Cardiothoracic Surgeons for Northwest Ohio
Cardiothoracic Surgeons for Northwest Ohio is a member of ProMedica Heart and Vascular Institutes, a collaboration of physicians, technology and specialty services. The group provides a comprehensive scope of leading edge patient care and state-of-the-art surgical procedures, including minimally invasive procedures, bloodless surgery, pediatric cardiac surgery, aortic valve repair and replacement and more. Its team of board-certified physicians, specialists and medical staff make up the largest cardiothoracic surgical program in northwest Ohio.

For more information about cardiac services at ProMedica Health System, visit www.promedica.org

Cardiothoracic Surgeons for Northwest Ohio and The Toledo Hospital are members of ProMedica Health System. ProMedica, a mission-based organization, was formed in 1986 and is a Toledo, Ohio-based, not-for-profit healthcare organization with more than 14,000 employees; 3,000 physicians and more than 306 facilities in Ohio and Michigan. ProMedica serves more than 2.73 million patients annually and includes 11 hospitals; ProMedica Continuum Services with senior, hospice, rehabilitation, and integrative services; ProMedica Physician Group, a network of more than 315 primary care and specialty physicians; and Paramount Health Care, the largest HMO in northwest Ohio. For more information, please visit www.promedica.org.

MONTVALE, NJ–(Marketwire – December 2, 2010) – SRS, the leader in productivity-enhancing EMR technology and services for high-performance specialty practices, today announced that it will seek certification of its EMR by the Office of the National Coordinator for Health Information Technology (ONC) under the American Recovery and Reinvestment Act (ARRA). Physicians will be able to use the EMR to successfully demonstrate meaningful use and qualify for the government’s incentives. SRS is unique among EMRs in its approach to meaningful use — combining the government’s requirements and desire for data with the acknowledged productivity and efficiency benefits that over 5,000 providers are already experiencing, and for which SRS is valued.

“SRS is unwavering in its adherence to a set of principles that are physician-based and productivity-driven,” says Evan Steele, CEO of SRSsoft. “Our product-development resources are consistently focused on providing physicians with tools that enable them to deliver the highest quality patient care in the most efficient manner. We listen to our customers, and we represent ‘the voice of the physicians,’ which includes advocating for their interests in Washington.

“We have been analyzing the legislation since its passage in February 2009 and continue to evaluate the impact that meeting meaningful use measures will have on physician productivity. In addition, we have challenged the program’s relevance for specialists. Since the release of the Final Rule on meaningful use a few months ago, the landscape has shifted, and several factors have influenced our decision to move forward with certification. Most recently, David Blumenthal’s clarification of the exclusions that can be claimed by many specialists has made participation more inviting. Our clients — primary care and specialists — who are interested in pursuing meaningful use want to have the assurance that the capability will be available to them.”

According to Steele, “The development team at SRS has been working diligently to incorporate the government’s data and communication requirements into our workflow-driven EMR. The uniqueness of the SRS approach to electronic medical records software — Unified Desktop™, open architecture, and browser-based platform — is the key to our ability to deliver productivity-focused meaningful use.”

About SRS
SRS is the leading provider of productivity-enhancing EMR technology and services for high-performance specialty practices — with a successful adoption rate unparalleled in the industry. Offered via the Unified Desktop™, its robust EMR, SRS CareTracker PM, and SRS PACS increase speed and efficiency, free physicians’ time, boost revenue, slash overhead, and enhance patient care and satisfaction. For more information on SRS, visit www.srssoft.com, e-mail [email protected], fax 201.802.1301, or call 800.288.8369.

MOUNTAINSIDE, NJ–(Marketwire – December 2, 2010) – Proteonomix, Inc. (OTCBB: PROT) (“Proteonomix” or the “Company”) announced today that it has updated its corporate website (http://www.proteonomix.com/) to reflect the dynamic growth and investment opportunity that exists today.

Michael Cohen, CEO stated: “The mission of Proteonomix, Inc. is to achieve a leadership position in life enhancing regenerative stem cell therapies, services, and products through a combination of first to market technologies and innovative clinical trial strategies. Stem cell treatment provides much promise for the treatment of diseases previously regarded as incurable. Through years of research and development, Proteonomix has developed breakthroughs in stem cell therapies for disease and injury, identification biomarkers and reproductive cell/tissue laboratory services.”

“Proteonomix is now actively negotiating strategic partnerships and opportunities for its breakthrough products and technology. We are currently in negotiations to joint venture our patents and intellectual properties with various entities and will be updating the investment community as these milestones are completed,” concluded Mr. Cohen.

About Proteonomix, Inc.
Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development of therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. Please also visit http://www.proteonomix.com/, http://www.proteoderm.com/, http://www.otcqb.com/ and http://www.sec.gov/.

Forward-looking statements: Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. More specifically, the investment may never occur negating the agreement, product performance and/or side effects may necessitate termination of the joint venture, the implementation of the agreement may not succeed and inadequate or no business may develop causing the failure of the joint venture and there are inherent risks in foreign operations, particularly those in the Mideast. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Click here to see all recent news from this company

BURNS, TN–(Marketwire – December 2, 2010) – New Life Lodge drug and alcohol addiction treatment center, in conjunction with parent company CRC Health Group, the nation’s largest provider of behavioral health and addiction treatment services, today announced the completion of the multi-facility acquisition of Recovery Living Services (RLS) in Tennessee. 

“We are pleased to acquire RLS, which has been providing high quality addiction treatment services for over five years, and to expand the outreach and breadth of services of New Life Lodge,” said Jerry Rhodes, President of the Recovery Division of CRC Health Group. “There are a number of Tennesseans who are dependent on drugs or alcohol and are in desperate need of quality recovery services. We want to help these individuals in their pursuit to reclaim their lives.”

According to the Substance Abuse and Mental Health Services Administration’s (SAMHSA) most recent National Survey on Drug Use and Health, approximately 444,000 (9%) of Tennessee citizens ages 12 or older reported past month use of an illicit drug, with 151,000 citizens reporting dependence or abuse of an illicit drug within the past year. Yet in 2008 (most recent year of data), there were only 9,806 admissions to drug/alcohol treatment centers in Tennessee. Approximately 129,000 Tennessee citizens reported needing but not receiving treatment for illicit drug use.

RLS provides substance abuse treatment for adults and adolescents as well as in-home behavioral health counseling services for at-risk youth. The acquired facilities — located in Downtown Knoxville, West Knoxville, Cookeville, Jamestown and Jacksboro — will continue to provide intensive outpatient program (IOP) services, outpatient opiate (Suboxone-based) detoxification services, and intensive in-home services. In addition, plans are underway to open two additional facilities in Chattanooga and Memphis.

Rebecca Gaskin, LCSW, CAC, MSW, MBA and current Executive Director of New Life Lodge, will oversee the additional facilities. Current CEO of Recovery Living Services, George Massengill, will stay on with CRC Health Group.

“I am very excited to have Recovery Living Services join the New Life Lodge family to serve persons struggling with substance abuse disorders throughout the state of Tennessee,” said Gaskin. “New Life Lodge is committed to providing high quality, effective treatment and RLS has demonstrated the same commitment in outpatient treatment settings throughout the eastern Tennessee area. This partnership will allow New Life Lodge to offer a seamless array of treatment opportunities for individuals to optimize their residential treatment experience and support them as they integrate back into their home environments.”

Gaskin added, “We hope to make our services widely available to those struggling with addiction by expanding our outpatient facilities across the state.”

New Life Lodge has been providing rehabilitation and treatment services for adults and adolescents struggling with alcohol and drug dependency for over 25 years. The treatment center acknowledges that addiction affects the entire family and therefore embraces the family as well as the individual to provide personalized treatment services. Under the supervision of licensed professionals, New Life Lodge has built a nationally recognized reputation and established long-standing relationships within the medical and mental health communities. The program is licensed by the Tennessee Department of Health and the Tennessee Department of Healthcare Facilities, and is CARF-accredited. For more information, visit www.newlifelodge.com.

New Life Lodge is a member of CRC Health Group, the most comprehensive network of specialized behavioral care services in the nation. CRC offers the largest array of personalized treatment options, allowing individuals, families and professionals to choose the most appropriate treatment setting for their behavioral, addiction, weight management and therapeutic education needs. CRC is committed to making its services widely and easily available, while maintaining a passion for delivering advanced treatment. Since 1995, CRC has been helping individuals and families reclaim and enrich their lives.
For more information, visit www.crchealth.com or call (877) 637-6237.

LOS ANGELES, CA–(Marketwire – December 2, 2010) – MMRGlobal, Inc. (OTCBB: MMRF) (MMR) and Texas-based MMX Holdings, LLC, today announced integration of MMRPro into the MMX dashboard-based financial and operating management tool for ambulatory surgical centers (ASCs) (www.managemyasc.com). The Company’s MMRPro electronic document management system for healthcare professionals will be featured on the Manage My ASC dashboard and as a result marketed to thousands of surgery centers located throughout the United States.

The Manage My ASC system was specifically designed to increase productivity and profitability in surgery centers which should help drive sales of MMRPro. As part of the transaction, MMRGlobal became a minority equity holder of MMX Holdings and MMX acquired 750,000 warrants in MMRF at terms and conditions that include purchase prices up to 18 cents per share.

“This transaction demonstrates how MMR can use its equity to create relationships that will allow us to expand our Electronic Medical Record product and service offerings in a coordinated effort to deliver meaningful use to healthcare professionals,” said Robert H. Lorsch, MMRGlobal Chairman and CEO. “It is the most recent example of the Company’s plan to deliver a suite of health information products and services through strategic alliances, partnerships and acquisitions. In addition to MMRPro and the MyMedicalRecords Personal Health Record, these could include one or more Electronic Medical Record products that run on different platforms including the iPad.”

“The opportunity for MMR to sell its services to a targeted market such as surgery centers offers a unique revenue opportunity for the Company,” Lorsch added. “We will continue to explore similar relationships in radiology, hospital systems, veterinary medicine and other specialties.” Lorsch is already a major shareholder and board member of Dancing Paws, a manufacturer of veterinary vitamins, supplements and treats including green bones.

According to John R. Seitz, CEO of Manage My ASC, “The relationship with MMR is one example of how our Manage My ASC Dashboard can streamline the operations of a surgery center and make it operate more effectively and profitably. Surgery centers receive a lot of different types of documents from referring physicians and MMRPro integrated with the dashboard can help manage and consolidate all patient records from any EMR or plain paper-based system employed by the center.”

The relationship with MMX evolved as a result of MMR’s installation of MMRPro at the Spalding Surgical Center of Beverly Hills. Installing MMRPro at Spalding exposed the system to more than 20 physician groups operating at the center at any given time. The Company quickly realized that selling through surgery centers represented a cost-effective way to market MMRPro to physicians. The Manage My ASC Dashboard creates the opportunity to provide a hands-on experience to tens of thousands of physicians referring to or operating at surgery centers when compared to the cost of selling offices of individual healthcare professionals one by one. 

“With over 6,000 in the U.S., ambulatory surgery centers are one of the fastest-growing elements of medical care across the country. Surgery centers will generally support 20 to 30 doctors, each with a patient list of 2,000 or more. The surgery center environment presents a distinctive market for MMR to offer its MMRPro solutions to significant physician populations. We are pleased that MMR is joining other well-known entities, including Kerlan-Jobe, one of the world’s foremost sports medicine destinations,” Seitz added.

MMRPro allows physicians working out of a surgery center to have electronic access to patient documentation, regardless of the system currently used in their offices, and enables the ASC to receive medical records securely from all their treating physicians. The system also cost-effectively digitizes and securely uploads medical records and makes them available to patients in real time while generating stimulus money to referring physicians.

The MMRPro solution is supported by Kodak’s Scan Station 520MDP. Surgery centers may also participate in the MMRPro Stimulus Program. As a result, a surgery center can participate in potentially hundreds of thousands of dollars of recurring upgrade revenue annually coming from the thousands of patients treated at the surgery centers at any given time when contrasted to the number of patients in a typical MMRPro group practice installation. The MMRPro Stimulus Program provides funds to physicians, hospitals and alternative care facilities for patient upgrades to a full-featured MyMedicalRecords Personal Health Record in addition to stimulus monies that may be provided by the federal government.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

About Manage My ASC

Manage My ASC combines timely and focused management reporting, backed-up by our team of industry experts, to deliver management solutions to ASC owners and operators. Our easy to understand on-line dashboard is a powerful management tool and serves as a central reference point for you to view and track your ASC’s activities. Plus, your dashboard is the main meeting point for you and our experts who are there to help you interpret results and take action.

The Manage My ASC solution works for any ASC, regardless of size or geographic location. Manage My ASC customers receive periodic reviews of operation performance, including assessments based on our comprehensive benchmarking database, that lead to specific recommendations to capture improvement opportunities. www.managemyasc.com

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including future performance, management’s expectations, beliefs, intentions, estimates or projections, constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “help,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of these words. . Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company’s products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in physician practices, surgery centers and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company’s marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company’s filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. MMRGlobal, Inc. is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Click here to see all recent news from this company

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Dec. 2, 2010) – Premier Diagnostic Health Services Inc. (CNSX:PDH) (“PDH”) announces Denis Tusar, CEO – China Operations for PDH, is departing to China, on Saturday, December 4, 2010 to meet with the on-the-ground China Development Team. 

The Team will work under his supervision to negotiate and finalize four to six contracts with qualifying hospitals for the establishment of Centers for Advanced Diagnostics that will utilize PET-CT technology for detection and evaluation of cancer. 

Working from the model established by PDH in collaboration with the No. 3 Armed Police Hospital in Beijing where the first Center has been operating an MRI scanner for three months, PDH will provide and own the PET-CT scanners. The Centers will be operated in collaboration with the hospitals over a 10 – 12 year period with positive revenues expected to be generated from the outset.

PDH is retaining the services of a senior executive from a major Chinese Trading Company to head up the China Development Team. 

About Premier Diagnostic Health Services Inc. (CNSX:PDH)

As leaders in advanced health and education with the international medical community, PDH is rolling out its global strategy of establishing a network of Centres for Advanced Diagnostics in Canada and China. By utilizing MRI and PET-CT, the most advanced medical diagnostic imaging technology available and the production of FDG, the radiopharmaceutical tracer used in oncology PET procedures; PDH is uniquely positioned to deliver continued innovation, growth and profitability.

PHILADELPHIA, PA–(Marketwire – December 2, 2010) – Sullivan, Cotter and Associates, Inc., a health care compensation and human resource management consulting firm, has announced the opening of its newest business location in Philadelphia. With offices in the major markets of Atlanta, Boston, Chicago, Detroit, New York, Parsippany, San Francisco and Westport, Philadelphia was a natural additional market for the nationally regarded compensation consulting firm. The new location is at 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428.

“We are enthusiastic about our continued growth in the east coast. Our presence in Philadelphia will allow us to meet our commitment to superior client service and accessibility for local health care organizations,” notes SullivanCotter Managing Director, Chris Terranova. “SullivanCotter’s compensation strategies ensure that organizations are in compliance with a myriad of regulatory matters while also being sensitive to the concerns of their boards,” Terranova adds.

Bruce Greenblatt will open the Philadelphia office as a Principal of the Firm. Greenblatt has more than 14 years of consulting experience with particular expertise in executive compensation in the health care industry, as well as the consumer products, manufacturing and communications industries. He has advised the senior management and boards of nonprofit, publicly-traded and private companies on compensation strategy as well as in the design and implementation of executive incentive and other programs.

Sullivan, Cotter and Associates, Inc. specializes in the assessment and development of total compensation and reward programs for executives and physicians in the health care industry. Since 1992, SullivanCotter has worked closely with health care organization executives, boards and compensation committees to devise innovative compensation solutions that attract and retain leadership talent while satisfying not-for-profit missions and regulatory requirements. A leader in independent consulting, benchmarking, trends and analyses, SullivanCotter has also developed the most widely recognized physician and executive compensation surveys in the United States. For more information, visit www.sullivancotter.com or call 888-739-7039 toll-free. In Philadelphia, please call 484-534-2922.

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Dec. 2, 2010) – ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCQB:APCSF) (the “Company”) announces that new tests have shown that T³6^® Antiseptic Hand Sanitizer is completely effective against two types of new “superbugs” within 15 seconds. The testing was conducted at BioScience Laboratories in Bozeman, MT against antibiotic-resistant strains of E. coli and Klebsiella. These strains have taken genes from other bacteria that have developed the ability to digest nearly all antibiotics, including penicillin-like antibiotics that possess broad spectrum antibacterial properties and are typically used as a last resort. Such genetic “swapping” is common among bacteria and is a major cause of antibiotic resistance.

Dr. Terrance Owen, President & CEO comments, “T³6^® Antiseptic Hand Sanitizer works in a completely different way than antibiotics. It kills infectious organisms by disrupting their cell walls so the presence of antibiotic-digesting enzymes does not stop it from working. Since these infections are so dangerous, it is important to prevent them from happening in the first place. Proper hygiene, including the use the of hand sanitizers and disinfectants such as T³6^® Antiseptic Hand Sanitizer and T³6^® Disinfectant, is a very important step in preventing the spread of potentially incurable diseases.”

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived from its patented T³6^® technology. The Company trades on the TSX Venture Exchange under the symbol APH and on the OTCQB under the symbol APCSF. The Company was the Official Supplier to the Vancouver 2010 Olympic Winter Games and the Vancouver 2010 Paralympic Winter Games and is the Official Supplier to the Canadian Olympic Committee, the 2010 Canadian Olympic Team and the 2012 Canadian Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant cleaning products. The Company was also selected as one of the TSX Venture 50 companies in the Technology and Life Sciences sector for 2010.

Terrance G. Owen, Ph.D., MBA
President & CEO
ALDA Pharmaceuticals Corp.
www.aldacorp.com

The Units, common shares, warrants and the common shares issuable upon exercise of the warrants have not been registered under the United States Securities Act of 1933 (the “Act”) and may not be offered or sold absent registration under the Act or an applicable exemption from the registration requirements thereof. This news release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction or an exemption therefrom.

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA’s expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as “outlook”, “will”, “could”, “would”, “might”, “remains”, “to be”, “plans”, “believes”, “may”, “expects”, “intends”, “anticipates”, “estimate”, “future”, “plan”, “positioned”, “potential”, “project”, “remain”, “scheduled”, “set to”, “subject to”, “upcoming”, and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

RYE BROOK, NY–(Marketwire – December 2, 2010) – CBLPath today announced that it is now officially part of Sonic Healthcare Limited’s federation of laboratories.

CBLPath will work closely with Sonic’s clinical laboratory divisions to cross sell services to their respective referrer bases. Significant revenue synergies are expected to be realized from the cross sell opportunities in FY2012 and following years. In addition, there are a number of cost synergies which Sonic can offer CBLPath, particularly in the areas of logistics, purchasing and billing.

CBLPath has been operating under the direction of the Office of the CEO comprised of David W. Bryant, President and Chairman of the Board; Dr. Carlos D. Urmacher, Chief Medical Officer; and Joe Sinicropi, Chief Operating Officer. At this time, the Office of the CEO will be disbanded and Mr. Bryant will assume the role of CBLPath’s Chief Executive Officer. Dr. Urmacher will continue in his role as Chief Medical Officer and Mr. Sinicropi in his role as Chief Operating Officer.

The company will continue to operate under the CBLPath name.

About CBLPath
CBLPath is a national specialty lab offering a full convergence of anatomic, molecular and digital pathology services. The company provides a one-stop solution for comprehensive sub-specialized diagnostics, and timely, accurate, patient-centered disease management guidance. Through its Best Practice™ Partnership Program, CBLPath partners with pathologists to help them grow their practices, while giving them the ability to stay independent and “keep medicine local.” The company also provides sub-specialty physicians access to comprehensive, high-quality testing in their local market. Founded in 1988, CBLPath established a reputation for providing timely, highly accurate diagnoses along with extraordinary customer service and a true patient-centered commitment. For more about the company, please visit www.CBLPath.com.

About Sonic Healthcare Limited
Sonic Healthcare is one of the world’s largest medical diagnostics companies, providing laboratory and radiology services to medical practitioners, hospitals, community health services, and their collective patients. Sonic Healthcare Limited is the parent company of the many operating companies around the world comprising the Sonic Healthcare group. It is a public company, listed on the Australian Securities Exchange (ASX), where it is classified as one of Australia’s “Top 100” companies. Sonic Healthcare has its head office at Macquarie Park in Sydney, Australia, in the same building as the main Douglass Hanly Moir Pathology laboratory. In the medical arena, their success is based on the fact that Sonic Healthcare companies are recognized as quality diagnostic practices that have remained true to the ethical principles of the medical profession. For more about the company, please visit www.sonichealthcare.com.

CHATHAM, NJ–(Marketwire – December 2, 2010) – Today, MediMedia announced the consolidation of two of its largest divisions: Krames Patient Education and StayWell Custom Communications. Industry-leaders in their respective fields, the two organizations will join forces to create a combined company that will be the largest provider of interactive and print patient education solutions and consumer health information in the country. The Krames StayWell team will have an unmatched market presence including nearly 80 sales and account executives, more than 80 product developers and designers, nearly 45 interactive solution developers and technology specialists, and 25 dedicated client services professionals. The two companies will combine into one organization effective January 1, 2011, to be called Krames StayWell.

“There is really only one reason we are taking this action, and it is a powerful one,” said MediMedia CEO Steve Simcox. “We believe that by consolidating our extensive technology and content assets, product development expertise, and client services resources, we can drive greater value for our clients.”

The consolidation is designed to build on the combined strengths of both organizations, allowing Krames StayWell to more easily offer seamless access to a wider breadth of products, consultative professional expertise, technology, and content assets. “There is no question that we can serve client needs better together than separately,” said Patrick Clifford, StayWell Company Chairman.

“Our goal is to make it even easier for our clients to do business with us,” said George Parker, President and CEO of Krames, who will serve as CEO of Krames StayWell. “We will be able to provide enterprise-wide and market-specific solutions designed to drive consumer engagement, improve health outcomes, and lower healthcare costs with unmatched ability to integrate print and interactive solutions. Krames StayWell is uniquely positioned to deliver ROI to our clients across all healthcare markets.”

The executive leadership teams of Krames and StayWell Custom Communications will remain intact, and will combine in new roles. “This is a team that has worked together for an extensive period of time, knows each other well, and thrives on the spirit of collaboration and innovation offered by this consolidation,” said Trent Sterling, President and CEO of StayWell Custom Communications, who will serve as President for the new organization. The company will have more than 330 employees located throughout the country. 

Krames StayWell will represent best-in-class health communication solutions across the entire spectrum of consumer engagement. Products from the combined organizations are used by more than 85% of American hospitals, as well as leading health plans, employers, pharmaceutical companies, retail organizations, and thousands of healthcare professionals in multiple care settings.

Krames Patient Education has a long history of creating exceptional patient education solutions, in print and interactive formats, rooted in patient-centric content created in consideration of health literacy design principles. Krames flagship products designed to initiate positive patient health self-management at the point of care include:

• Krames On-Demand™ — an electronic, print on-demand system featuring more than 5,300 single topic HealthSheet™ articles covering 38 medical specialty areas and spanning 12 languages.
• Krames Exit-Writer™ — an electronic emergency department discharge instruction program featuring more than 1,400 discharge instruction covering the most common diagnoses addressed in the ER/Urgent care environment plus a prescription writer and medication reconciliation tool.
• Krames Video Solutions™ — A suite of tools enabling delivery of more than 430 Patient Education videos spanning nine languages via websites, point of care tools, kiosks, CCTV systems and DVDs.
• Krames Patient Consent™ — An electronic system designed to standardize and streamline the informed consent process. Via the creation of personalized, procedure specific legal forms and companion patient education written in plain language, Krames Patient Consent™ ensures better patient-provider communication improving outcomes while mitigating legal risk.
• Krames Go-to-Guides™ — A suite of interactive, multimedia disease management workbooks featuring narrated text, embedded video, and quizzes for learning verification designed to match the learning preferences of almost any patient.
• Krames Print Materials™ — An award-winning library of more than 1,300 booklets, brochures, tear sheets, and other formats featuring Krames signature art-text synergy.

StayWell Custom Communications has a legacy of creating print and interactive health information and health management communications designed to help healthcare organizations engage and motivate consumers, and deliver measurable ROI. The company will contribute a wide range of award-winning solutions to the new organization, ranging across digital, mobile, print, SEO and professional services:

• Digital — interactive health libraries and health portals offer more than 30,000 interactive content assets, and include the widely used StayWell Solutions Online™ and StayWell Engage™; microsites, video, email, animations, podcasts and symptom checkers;
• Mobile — text messaging programs, mobile sites, symptom checker for the iPhone, event promotion, contact center solutions and custom applications;
• Custom Print Solutions — more than 100 million copies each year of award-winning publications and other print communications for community, member, disease management and client-selected audiences;
• Search Engine Optimization (SEO) — local search, keyword optimization and conversion optimization; and
• Professional Services — content integration consultation, Return-on-Investment (ROI) measurement, media integration strategy, and consultative strategy support for creating comprehensive multi-media communications solutions that engage consumers and deliver results.

Both organizations have been committed to helping their clients achieve better health outcomes for consumers for decades. Now united, Krames StayWell is uniquely positioned to provide comprehensive, multimedia health information and communication solutions across multiple consumer touch points — delivering the engaging healthcare information patients and consumers want, when they want it and how they want it, and with a focus on generating measurable results for their clients.

About Krames

Krames (a MediMedia Company) is the market leader in patient education and consumer health information solutions. More than 85 percent of American hospitals, as well as leading health plans, employer groups, private practices and pharmaceutical companies use Krames’ solutions to improve quality of care, streamline workflow and lower healthcare costs. Krames also brings health literacy expertise to American Heart Association/ American Stroke Association and American Lung Association patient education through exclusive partnerships with these respected organizations. Founded in 1974, Krames remains at the leading edge of patient education with innovative programs that utilize a comprehensive suite of print, electronic and video content.

For more information, please visit www.krames.com

About StayWell Custom Communications

StayWell Custom Communications (a MediMedia Company) is the leader in custom health content solutions delivered via a variety of sophisticated technology platforms. Our interactive offerings include robust web platforms, online health libraries, e-mail and mobile marketing programs, an extensive range of multimedia tools including video, podcasts and animations, and health management tools and programs. StayWell Custom Communications also offers a comprehensive range of print and print/interactive integrated solutions to meet a broad range of clients’ marketing and communication needs. The company serves hundreds of clients representing several channels in the healthcare industry: hospitals and health systems; health plans; employers; and retail organizations.

For more information, please visit www.staywellcustom.com

About MediMedia

Headquartered in Yardley, PA, with 1,700 employees in offices throughout the U.S., MediMedia changes consumer and professional behaviors through superior engagement, education and end-user preferences. Our health information services group creates, publishes, distributes, and syndicates on and off-line health information to help consumers make informed health decisions on behalf of a variety of sponsors, including providers — both hospitals and physicians, payers, and online media companies. Our health management services group provides population health management services which help consumers lower their health risk, enabling employers to lower their risks, utilization and ultimately their health care expenses. And finally, our professional segment derives its revenues from providing online/off-line professional promotion, engagement, and education services targeted to healthcare professionals and their patients

MediMedia is a Vestar Capital Partners portfolio company.

Click here to see all recent news from this company

ORLANDO, FL–(Marketwire – December 1, 2010) – WellTek, Inc. (OTCBB: WTKN), a global health, fitness and wellness company, announced today that it plans to expand into the virtual event market, specializing in the healthcare and wellness niche, by launching a new wholly-owned company, WellTek Events, Inc. This next-generation virtual event platform will serve as the foundation in allowing WellTek and other brands to actively reach, engage and influence health and wellness conscious consumers with new and existing brand assets, technologies, products and services.

According to the Virtual Conference and Trade Show Market Study 2010-2015, the worldwide virtual conference and trade show market is forecasted to grow at a compound annual growth rate (CAGR) of 56% between the period of 2010 and 2015 and to generate $18.6 billion in revenues over the period 2010 – 2015. While the virtual event market is still in its infancy, WellTek intends to launch into the virtual event business.

WellTek Events is looking to become the industry leader in producing and delivering powerful virtual events for the healthcare and wellness market — linking exhibitors, attendees, and thought leaders together in a fully immersive and engaging virtual environment. 

Without the costs, hassles and time involved in a physical event, participants navigate through the 3D game-like world booth by booth via an avatar. Advances in technology allow exhibitors to actively reach, engage and influence a highly targeted global audience, create and customize virtual booths, communicate with prospects via video conferencing and live chat, convert leads to customers in real-time with the Ecommerce platform, generate reports and analytics to tract ROI and many more features that ultimately turn prospects into buyers and customers into raving fans.

The integration of virtual events, social networking and social gaming permits attendees to overcome the challenges facing the traditional trade show market, as well as take advantage of the benefits of social media: staying in constant contact, sharing opinions, recommendations and links, getting answers right away and feeling connected to the information they care most about — all while being entertained.

Randy Lubinsky, Chairman and CEO of WellTek, stated, “With over 40 years experience in the medical industry and interacting with physicians, we believe we can leverage our expertise to establish WellTek Events as the premiere company for virtual medical conferences and wellness events.”

In an effort to focus time and capital on WellTek Events, the company has decided to rescind the acquisition of its 51% interest in WellCity, Inc. As part of the rescission, 14,500,000 shares of WellTek common stock will be returned to WellTek and the financial position of both companies will return to that prior to the May 1, 2010 acquisition.

In addition, WellTek has also effectuated a 50 to 1 reverse split as of December 2, 2010 in order to facilitate raising additional growth capital.

About WellTek Incorporated
WellTek is a global health, fitness and wellness company that provides proven solutions to help address some of the world’s most pressing and costly health and wellness challenges. The Company owns and operates WellTek Events, Inc., a fully engaging virtual event platform specializing in the healthcare and wellness market. The Company’s subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. For more information on the Company, please contact [email protected] or visit www.WellTekinc.com. 

Certain statements contained in this press release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company’s Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company’s ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel — including highly qualified executives, management and operational personnel, ability to negotiate favorable future debt facilities and capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will, in fact, occur. 

MISSION, KS–(Marketwire – December 1, 2010) – PPM Information Solutions, Inc. (PPMIS) (www.ppmconnect.com) publishes “The Practice Readiness Roadmap — your route to a successful start.” Dedicated to serving the anesthesia community, PPMIS is forging its presence in the medical community and delivering its guide for assisting physicians who are considering starting a practice or moving to a new software vendor or billing service. Download a free copy.

For over a decade, PPMIS has developed first-rate software for medical billing solutions. Formed by anesthesiologists to serve the anesthesia specialty, the company’s goal is providing its clients with industry-leading software products and services. Because PPMIS understands the complexity of billing for anesthesia, its products and services take the everyday complications out of medical billing.

The company’s newest platform, a SaaS model, is medical billing software with flexibility, a full range of reporting options, and strictly enforced exception edits, ensuring claim accuracy that result in prompt reimbursement. The fully integrated Connect platform provides accelerated claims processing, streamlined collections management, and reporting capabilities.

RCM Services, its full-service medical billing service, offers multi-specialty billing, certified coding, SaaS technology, demographic and EMR downloads, payer credentialing, and practice advocacy. Proven metrics ensure the success of the client’s practice. The company believes when the client succeeds, it succeeds. Learn more about PPMIS practice management services.

About PPM Information Solutions, Inc.
PPMIS is a medical billing provider that helps clients recognize revenue faster by submitting clean claims. The company offers both billing software and billing services as its medical billing solutions. This U.S. based company does 100% of its software development at its headquarters in Mission, KS. Its staff is dedicated to delivering the most comprehensive solutions available for medical billing. PPMIS billing solutions and the Practice Readiness Roadmap free practice assessment can be found at www.ppmconnect.com.

Direct inquiries to [email protected], or contact Manolito Jones or Dan Olin at 913-262-2332 to request a product demonstration.

Click here to see all recent news from this company